March 13 – 16, 2023 | London

Celebrating 13 years and 13 approved ADC’s, World ADC is back and better than ever this March.

With over 211 antibody-drug conjugate clinical trials breaking ground throughout 2022, a plethora of positive clinical results, expansion of antibody-drug conjugates to novel indications, an exponential increase in investments and collaborations, and the industry-changing recent approval of ImmunoGen’s ELAHEREthere has been no more important time to invest in progressing your ADCs and unite the community.

Uniting 400+ peers of the ADC community, including Beacon’s ADC Insight Lead, Jake Morris, with an exclusive presentation exploring ‘The Current State of the ADC Landscape‘, the highly anticipated 13th World ADC London is Europe’s only discussion and networking forum dedicated to addressing and overcoming the challenges in end-to-end ADC development.